FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q53236914> ?p ?o ?g. }

• Q53236914 description "2011 nî lūn-bûn" @default.
• Q53236914 description "2011年の論文" @default.
• Q53236914 description "2011年学术文章" @default.
• Q53236914 description "2011年学术文章" @default.
• Q53236914 description "2011年学术文章" @default.
• Q53236914 description "2011年学术文章" @default.
• Q53236914 description "2011年学术文章" @default.
• Q53236914 description "2011年学术文章" @default.
• Q53236914 description "2011年學術文章" @default.
• Q53236914 description "2011年學術文章" @default.
• Q53236914 description "2011年學術文章" @default.
• Q53236914 description "2011年學術文章" @default.
• Q53236914 description "2011年學術文章" @default.
• Q53236914 description "2011년 논문" @default.
• Q53236914 description "article científic" @default.
• Q53236914 description "article scientific" @default.
• Q53236914 description "article scientifique" @default.
• Q53236914 description "articol științific" @default.
• Q53236914 description "articolo scientifico" @default.
• Q53236914 description "artigo científico" @default.
• Q53236914 description "artigo científico" @default.
• Q53236914 description "artigo científico" @default.
• Q53236914 description "artikel ilmiah" @default.
• Q53236914 description "artikull shkencor" @default.
• Q53236914 description "artikulong pang-agham" @default.
• Q53236914 description "artykuł naukowy" @default.
• Q53236914 description "artículo científico publicado en 2011" @default.
• Q53236914 description "artículu científicu" @default.
• Q53236914 description "bilimsel makale" @default.
• Q53236914 description "bài báo khoa học" @default.
• Q53236914 description "naučni članak" @default.
• Q53236914 description "scienca artikolo" @default.
• Q53236914 description "scientific article published in September 2011" @default.
• Q53236914 description "scientific article published in September 2011" @default.
• Q53236914 description "scientific article published in September 2011" @default.
• Q53236914 description "teaduslik artikkel" @default.
• Q53236914 description "tieteellinen artikkeli" @default.
• Q53236914 description "tudományos cikk" @default.
• Q53236914 description "vedecký článok" @default.
• Q53236914 description "vetenskaplig artikel" @default.
• Q53236914 description "videnskabelig artikel" @default.
• Q53236914 description "vitenskapelig artikkel" @default.
• Q53236914 description "vitskapeleg artikkel" @default.
• Q53236914 description "vědecký článek" @default.
• Q53236914 description "wetenschappelijk artikel" @default.
• Q53236914 description "wissenschaftlicher Artikel" @default.
• Q53236914 description "επιστημονικό άρθρο" @default.
• Q53236914 description "мақолаи илмӣ" @default.
• Q53236914 description "наукова стаття, опублікована у вересні 2011" @default.
• Q53236914 description "научна статия" @default.
• Q53236914 description "научная статья" @default.
• Q53236914 description "научни чланак" @default.
• Q53236914 description "научни чланак" @default.
• Q53236914 description "מאמר מדעי" @default.
• Q53236914 description "مقالة علمية نشرت في سبتمبر 2011" @default.
• Q53236914 description "সেপ্টেম্বর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q53236914 description "บทความทางวิทยาศาสตร์" @default.
• Q53236914 description "სამეცნიერო სტატია" @default.
• Q53236914 name "A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer." @default.
• Q53236914 name "A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer." @default.
• Q53236914 type Item @default.
• Q53236914 label "A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer." @default.
• Q53236914 label "A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer." @default.
• Q53236914 prefLabel "A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer." @default.
• Q53236914 prefLabel "A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer." @default.
• Q53236914 P1433 Q53236914-5666D4A3-09A1-4FDC-B6E0-1572A482096A @default.
• Q53236914 P1476 Q53236914-8F3721EC-5856-494C-81DF-1B7A4E315064 @default.
• Q53236914 P2093 Q53236914-1012B82E-782C-461A-A4C3-583FC4D5BA71 @default.
• Q53236914 P2093 Q53236914-1AA234E0-0363-4401-8B8F-E99B7AD8FD38 @default.
• Q53236914 P2093 Q53236914-1D37CA88-3586-41AB-A932-95333F8142D3 @default.
• Q53236914 P2093 Q53236914-1FDE3DFF-F3A2-4CCD-8ADC-BD58798A0E0F @default.
• Q53236914 P2093 Q53236914-277FDC4B-BFAF-4D8B-BC13-ACA639561232 @default.
• Q53236914 P2093 Q53236914-6AD28A06-F5F1-4282-B185-4028B4C6FA85 @default.
• Q53236914 P2093 Q53236914-7EA810F6-887F-46E4-B766-4903C2B0F7D5 @default.
• Q53236914 P2093 Q53236914-8A84D510-9ED0-44C6-A58E-08CE43DAA701 @default.
• Q53236914 P2093 Q53236914-8EC2862F-677B-47A2-BBEF-142FA933A4AB @default.
• Q53236914 P2093 Q53236914-92597380-31CE-42D4-8EB5-DE03215525EA @default.
• Q53236914 P2093 Q53236914-94A627C3-B535-4FBF-97C2-351BB234CA1B @default.
• Q53236914 P2093 Q53236914-B01ECC4B-5D2A-4AEA-AE89-888C4A885CCC @default.
• Q53236914 P2093 Q53236914-C0E369CE-92FF-4330-9933-CEB3F4263D61 @default.
• Q53236914 P2093 Q53236914-D3CD84E3-BF95-43BC-9E2C-C2B6E9ECFB1F @default.
• Q53236914 P2093 Q53236914-E43ADD34-83D9-42F9-855D-A68C53DD4EE2 @default.
• Q53236914 P2093 Q53236914-FFE5AC9D-D8B6-427B-9F7A-2D7F87F5B544 @default.
• Q53236914 P304 Q53236914-4094A298-EEE9-4FA8-95FC-50AEA9CB0620 @default.
• Q53236914 P31 Q53236914-DD284EAE-66F5-4CC4-827E-10D9FEAD65F2 @default.
• Q53236914 P356 Q53236914-92FFBB32-E267-4BD8-B1A3-13696A953210 @default.
• Q53236914 P433 Q53236914-89C81215-9C88-4892-8011-932EC698B5DD @default.
• Q53236914 P478 Q53236914-3BF7FC32-F7A4-471C-8298-DAB357946ABF @default.
• Q53236914 P577 Q53236914-A904794B-E8A0-4018-BEA8-661DE08A0A85 @default.
• Q53236914 P698 Q53236914-C394D8B8-9DEB-467E-9B4A-088304E14BCF @default.
• Q53236914 P921 Q53236914-DFDDDEF1-E9FA-44FE-8DB3-1D4147370CDE @default.
• Q53236914 P356 JTO.0B013E3182210430 @default.
• Q53236914 P698 21716146 @default.
• Q53236914 P1433 Q2448056 @default.
• Q53236914 P1476 "A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer." @default.
• Q53236914 P2093 "Amy H Peterman" @default.
• Q53236914 P2093 "Carrie B Lee" @default.
• Q53236914 P2093 "Daniel S Bradford" @default.
• Q53236914 P2093 "Dominic T Moore" @default.
• Q53236914 P2093 "Edwin McElroy" @default.

• next